- Home
- NINE vs ENLV Comparison
NINE vs ENLV Comparison
Compare NINE & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- ENLV
- Stock Information
- Founded
- NINE 2011
- ENLV 2005
- Country
- NINE United States
- ENLV Israel
- Employees
- NINE N/A
- ENLV N/A
- Industry
- NINE Oilfield Services/Equipment
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- NINE Energy
- ENLV Health Care
- Exchange
- NINE Nasdaq
- ENLV Nasdaq
- Market Cap
- NINE 29.8M
- ENLV 25.3M
- IPO Year
- NINE 2018
- ENLV 1995
- Fundamental
- Price
- NINE $0.66
- ENLV $1.06
- Analyst Decision
- NINE
- ENLV Strong Buy
- Analyst Count
- NINE 0
- ENLV 2
- Target Price
- NINE N/A
- ENLV $10.00
- AVG Volume (30 Days)
- NINE 706.6K
- ENLV 1.2M
- Earning Date
- NINE 10-30-2025
- ENLV 08-29-2025
- Dividend Yield
- NINE N/A
- ENLV N/A
- EPS Growth
- NINE N/A
- ENLV N/A
- EPS
- NINE N/A
- ENLV N/A
- Revenue
- NINE $577,300,000.00
- ENLV N/A
- Revenue This Year
- NINE $4.56
- ENLV N/A
- Revenue Next Year
- NINE $1.41
- ENLV N/A
- P/E Ratio
- NINE N/A
- ENLV N/A
- Revenue Growth
- NINE 3.23
- ENLV N/A
- 52 Week Low
- NINE $0.44
- ENLV $0.81
- 52 Week High
- NINE $1.87
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- NINE 48.29
- ENLV 40.76
- Support Level
- NINE $0.64
- ENLV $1.01
- Resistance Level
- NINE $0.70
- ENLV $1.13
- Average True Range (ATR)
- NINE 0.05
- ENLV 0.11
- MACD
- NINE 0.01
- ENLV -0.02
- Stochastic Oscillator
- NINE 64.78
- ENLV 10.39
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.